Add to calendar 08/02/2018 02:00 PM08/05/2018 01:10 PMASH Meeting on Lymphoma BiologyAttend the 2018 ASH Meeting on Lymphoma Biology, taking place August 2-5 in the Washington, DC, metro area. The central goal of the meeting is to bring together experts from around the world to discuss the latest lymphoma fundamental science, address current challenges in the field, establish the highest priorities for investigation, and develop novel therapeutics.Westfields Marriott, Chantilly, VAMM/DD/YYYY129600
Get email updates
The ASH Meeting on Lymphoma Biology was established in 2014 to address an unmet need in the lymphoma community: to serve as the only U.S.-based forum specifically focused on basic and translational science relevant to lymphoma and chronic lymphocytic leukemia. The central goal of the meeting is to bring together experts from around the world to discuss the latest lymphoma fundamental science, address current challenges in the field, establish the highest priorities for investigation, and develop novel therapeutics.
This ACCME-accredited program consists of didactic sessions, abstract presentations, interactive workshops, and panel discussions. In addition, "Continuing Conversations" sessions offer a setting for informal, interactive discussions designed for meeting attendees to address issues relevant to the lymphoma community.
Through participation in this meeting, you will be able to:
- Discuss cutting-edge lymphoma research in a relaxed, informal setting.
- Present and hear newest unpublished results.
- Learn about current challenges in the field and the next steps to address those challenges.
- Establish collaborations with leading experts in academia and industry.
- Discuss how collaborative efforts can help accelerate the development of new therapeutic strategies.
- Interact with attendees and build your professional network.
- Earn CME and MOC credits.
The previous meetings (in 2014 and 2016) attracted more than 300 professional attendees from at least 20 countries outside of North America, including more than 65 trainees and junior researchers.
Who Should Attend?
- Laboratory-based investigators
- Translational investigators
- Junior faculty and trainees
- Life sciences and biopharmaceutical industry
- Policymakers and regulatory scientists
- Practitioners and other health professionals interested in lymphoma science
- Riccardo Dalla-Favera, MD, Columbia University
- Kojo Elenitoba-Johnson, MD, University of Pennsylvania
- Freda Stevenson, DPhil, University of Southampton Medical School
Steering Committee Members
- John Byrd, MD, The Ohio State University
- Elias Campo, MD, PhD, University of Barcelona
- Ralf Kuppers, PhD, University of Duisburg-Essen
- Ron Levy, MD, Stanford University
- Greg Nowakowski, MD, Mayo Clinic
- Margaret Shipp, MD, Dana-Farber Cancer Institute
- Louis Staudt, MD, PhD, National Cancer Institute, National Institutes of Health
- Catherine Wu, MD, Dana-Farber Cancer Institute
Please submit all general inquiries to email@example.com.
back to top